Saloni

Saloni

@scientificdiscovery.dev

Co-founder & editor, Works in Progress. Writer, Scientific Discovery. Podcaster, Hard Drugs. Advisor, Coefficient Giving. Newsletter: https://scientificdiscovery.dev Podcast: https://harddrugs.worksinprogress.co 🏳️‍🌈

47.3K followers1.1K following5.4K posts

Average econ IV paper be like: we reduced a thing by 8% and look at all the amazing consequences that had a decade later if you squint

Average vaccine paper be like: we reduced a thing by 99% and therefore just recommended it universally and now we can't study its long run effects in a randomized setting anymore oops

I feel incredibly relieved, but still that most people have no idea how difficult regular immigration routes are in the UK. I've lived here for more than 12 years already and still don't have citizenship because most of that was as a student (which didn't count) or interrupted (so the clock reset).

Funnily enough, I applied for the Royal Society to endorse me for the visa for my science background, but they passed it onto the British Academy who endorsed it under humanities instead. No explanation given.

Every time I hear friends share happily that their babies/toddlers slept a lot the previous night, I feel even prouder for having been a really sleepy kid. Totally nailed it

Saloni reposted

I reanalyzed the CDC data behind the LGB “free fall” headline. It rests on a change in bisexual identification among one grade, in one wave, of one survey. Gay or lesbian identification did not change significantly. Calling it a "free fall" is sensational and just gives bad actors talking points.

The Washington Post@washingtonpost.com

Young teenagers are less likely to identify as lesbian, gay or bisexual than a few years ago, according to a new analysis. “It really does look like a free fall,” Jean Twenge, a professor of psychology, said. “But what’s causing it is unclear.”

Saloni reposted

The more parsimoneous explanation is that infants express a preference for the Type G British/Irish electrical plug socket, which is objectively the best type of plug socket. This is evidence for innate rationality in newly born infants.

Dr Nick@nmwilkinson.eurosky.social

New paper! Accepted at Perspectives on Psychological Science. A textbook finding in infant psychology is that newborns - within ~1 hour of birth - visually track a simplified 'three blob' facelike stimulus further than its inverted control (see picture). This suggested inborn knowledge of faces!

Saloni reposted

It's interesting when you ask people to imagine what their life would be like if they were transported historically to the past. Some people seem to assume they'd be in the relatively well-off 1-2% and it would go fine for them. Meanwhile I just assume I'd be a secluded female peasant.

View full thread

But we think it’s just a matter of time before they can be used to target other organs too. Will siRNA treat diseases of other organs? And what’s the catch? Listen to our latest episode of HARD DRUGS to find out!

View full thread

• Long-lasting: some drugs last for months, even half a year, with a single injection • Off-the-shelf: they typically don’t involve complicated surgeries or procedures, because of the way they’re delivered in the body

Today, siRNA drugs are largely used to treat liver diseases, partly because that’s the easiest starting point. And they are extremely effective at it. One example is for cholesterol: siRNA drugs reduce PCSK9 levels by around 70%, reducing cholesterol levels by 50-60%, beyond the effect of statins.

View full thread

- Cardiovascular diseases, silencing proteins like PCSK9 that raise cholesterol - Cancers, by silencing proteins that help tumour cells grow, survive, metabolize, metastasize, or resist treatment - and more!

What’s even better is that siRNA drugs are: • Potentially tunable, meaning you could reduce the production of a protein, rather than silencing it entirely • Programmable, meaning you can quickly switch out which gene it targets by changing its sequence

siRNA drugs can ‘silence’ harmful genes in the body. And there are lots of cases where you might want to silence genes: - Infectious diseases, where you can silence pathogen proteins or human proteins that pathogens depend on - Rare genetic diseases, to silence the production of mutated proteins

View full thread

No matter how effective a new drug is, it won't make it to the finish line without funding and clinical trial infrastructure to test it in the first place.

In this game, your job is to speed up a phase three trial, by changing its design: You can recruit more participants, recruit them faster, increase drug efficacy, use surrogate endpoints and more. But as you'll notice, each faces diminishing returns...

In the end, you'll also learn that the same timeline can be sped up in multiple ways, but some levers matter much more than others. They also interact, and have diminishing returns. After a certain level, further improvements don't make much difference.

Saloni reposted

Happy Friday! Iʼve created a game for you to play! Will AI cure all diseases in 10 years? Inspired by bottlenecks discourse, I created a game to help build your intuitions. Play it here: game.clinicaltrialsabundance.blog Naturally, it’s bottle-themed with bubbles and there are leaderboards too.

Very fun to see how many people have played already. Each line here represents a successful completion, and there were many different ways to solve the game!

Saloni@scientificdiscovery.dev

Happy Friday! Iʼve created a game for you to play! Will AI cure all diseases in 10 years? Inspired by bottlenecks discourse, I created a game to help build your intuitions. Play it here: game.clinicaltrialsabundance.blog Naturally, it’s bottle-themed with bubbles and there are leaderboards too.

Happy Friday! Iʼve created a game for you to play! Will AI cure all diseases in 10 years? Inspired by bottlenecks discourse, I created a game to help build your intuitions. Play it here: game.clinicaltrialsabundance.blog Naturally, it’s bottle-themed with bubbles and there are leaderboards too.

Saloni reposted

New preprint! 🎉 I analysed 1660 papers from 4 psychology journals and found materials sharing went from 9% of papers in 2015 to 82% in 2025, and these materials *do* get downloaded — a median of 135 times each. BUT shared code is often hard to run. doi.org/10.31234/osf... Let's walk through it 🧵

Saloni reposted

This is an *excellent* post on cluster analysis. If you ever thought about applying cluster, latent class or latent profile analysis to psychological scales, you absolutely should read this!>

Jan Vanhove@janhove.bsky.social

New blog post: "Cluster analysis: A skeptic’s guide". In which I ask a few questions that social scientists wishing to identify hidden classes in their data ought to address. janhove.github.io/posts/2026-0...